A Study of the Effects of Itraconazole on the Plasma Levels of Nemtabrutinib (MK-1026-013)
Clinical trial NCT06688045 · COMPLETED
Trial details
- NCT number
- NCT06688045
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-30
- Primary completion
- 2024-01-06
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.